Abstract
Face-to-face communication during on-site monitoring is important for clinical trial quality assurance. However, with the coronavirus disease early 2020 pandemic, medical institutions placed restrictions on hospital visits to secure their medical systems.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have